Arrivo BioVentures Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $49M
Latest Deal Amount
  • Investors
  • 3

Arrivo BioVentures General Information


Developer of reformulated biopharmaceutical drugs designed to identify biologics and small molecules to improve patient care. The company's drugs are produced reformulated product or a new chemical entity, to identify regulatory strategies to expedite the path to approval through efficient clinical programs, enabling pharma/biotech companies to meet their drug demands to improve patient's lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Aerial Center Executive Park
  • 9001 Aerial Center Parkway, Suite 110
  • Morrisville, NC 27560
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrivo BioVentures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 25-May-2016 $49M 0000 Completed Generating Revenue
To view Arrivo BioVentures’s complete valuation and funding history, request access »

Arrivo BioVentures Executive Team (6)

Name Title Board Seat Contact Info
Stephen Butts Co-Founder, Chief Executive Officer & Manager
Karen Adams Chief Financial Officer
Michael Ackermann Ph.D Co-Founder, Manager, Chief Business Officer, Chief Operating Officer & Board Member
Jed Black MD Co-Founder & Scientific Advisor
William Wofford JD Co-Founder, Manager, General Counsel and Head of Corporate Development
You’re viewing 5 of 6 executive team members. Get the full list »

Arrivo BioVentures Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arrivo BioVentures Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Azur Pharma Corporation Minority 000 0000 000000 0
Rex Health Ventures Corporate Venture Capital Minority 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
To view Arrivo BioVentures’s complete investors history, request access »